These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 271071

  • 1. [Congestive cardiomyopathy after doxorubicin (adriamycin)author's transl)].
    Kaduk B, Seiler G.
    Dtsch Med Wochenschr; 1977 Dec 09; 102(49):1813-7. PubMed ID: 271071
    [Abstract] [Full Text] [Related]

  • 2. [Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin].
    Geidel S, Garn M, Grävinghoff L, Hausdorf G, Morf G, Bielack S, Knop J, Winkler K.
    Klin Padiatr; 1991 Dec 09; 203(4):257-61. PubMed ID: 1942931
    [Abstract] [Full Text] [Related]

  • 3. [Cardiotoxicity in long term treatment with cytostatics (author's transl)].
    Fuhrmann U, Rieger M, Franz Ch.
    Dtsch Med Wochenschr; 1978 Mar 03; 103(9):387-90. PubMed ID: 272983
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma.
    Longhi A, Ferrari S, Bacci G, Specchia S.
    Anticancer Drugs; 2007 Jul 03; 18(6):737-44. PubMed ID: 17762406
    [Abstract] [Full Text] [Related]

  • 5. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H, Toyota S, Takahara O, Ichimaru M.
    Rinsho Ketsueki; 1978 Aug 03; 19(8):1041-50. PubMed ID: 713049
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sudden cardiac death following adriamycin therapy.
    Couch RD, Loh KK, Sugino J.
    Cancer; 1981 Jul 01; 48(1):38-9. PubMed ID: 6940649
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Fatal myocardiopathy due to adriamycin in spite of a reportedly non-dangerous cumulative dose].
    Battin J, Richir C, Bui NB, Hehunstre JP, Abecassis S.
    Ann Pediatr (Paris); 1989 Feb 01; 36(2):136-40. PubMed ID: 2930128
    [Abstract] [Full Text] [Related]

  • 18. [Endomyocardial biopsy as a method of surveilling adriamycin cardiac toxicity. 28 biopsies in 26 patients].
    Bouhour JB, Petitier H, Delajartre AY, Fumoleau P, Rozo L, Nicolas G.
    Arch Mal Coeur Vaiss; 1983 Nov 01; 76(11):1277-83. PubMed ID: 6419695
    [Abstract] [Full Text] [Related]

  • 19. Adriamycin cardiomyopathy. Fatal outcome of general anaesthesia in a child with adriamycin cardiomyopathy.
    McQuillan PJ, Morgan BA, Ramwell J.
    Anaesthesia; 1988 Apr 01; 43(4):301-4. PubMed ID: 3377152
    [Abstract] [Full Text] [Related]

  • 20. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN.
    Clin Cancer Res; 1995 Jul 01; 1(7):691-7. PubMed ID: 9816034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.